Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLargo, formerly known as iVoice, is a diversified life sciences and environmental technology company that develops innovative solutions for clean water, clean air, and advanced healthcare. The company operates through several subsidiaries, most notably Clyra Medical Technologies, which focuses on advanced wound care and antimicrobial products. BioLargo's core technology platforms include the Advanced Oxidation System (AOS) for water treatment and CupriDyne for odor control and air quality. With a transition from its origins in speech recognition to a focus on sustainable engineering and medical devices, BioLargo now provides FDA-cleared products for infection control and is actively expanding its footprint in the PFAS remediation and clean energy sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iVoice.